The relationship between the degree of expression of matrix metalloproteinases or tissue inhibitor of metalloproteinases and venous reflux remains to be investigated. Materials and Methods: Primary varicose vein tissues were obtained from 23 patients, 18 females and 5 males, aged from 19 to 73. Cephalic or basilic veins were obtained for the control group from 10 patients who underwent vascular access for maintenance hemodialysis. Two operative techniques (high ligation with stripping or endovenous laser coagulation) were used. The expression of matrix metalloproteinase-2 and 13 and tissue inhibitor of metalloproteinase-4 in the varicose vein group and control group was assessed semi-quantitatively by immunohistochemical slides stained with primary antibodies. Results: Twenty (87%) of the varicose vein group patients had greater or lesser saphenous vein diseases with reflux. The focal weak (＋) stain for matrix metalloproteinases-2, and 13, and tissue inhibitor of matrix metalloproteinase-4 was dominant in the varicose vein group; the focal or diffuse strong stain (＋＋ or ＋＋＋) was prevalent in the control group. The differences were statistically significant (p＜0.01). The degree of reflux and the duration of symptoms were not significantly related to the expression of respectively). Conclusion: Further study should be performed to investigate the relationship between the clinical characteristics related to venous hypertension or reflux and expression of MMPs and TIMP in varicose veins.
INTRODUCTION
Reflux, or pathologic retrograde flow, caused by an incompetent venous valve has been reported as one of the most important etiologic factors of varicose veins (VV) in the lower extremities. Furthermore, venous hypertension followed by reflux can cause changes in the physical properties of the venous walls by increased expression of matrix metalloproteinases (MMPs), which will lead to a dilated and serpentine morphology of VV [1] . However, the relationship between venous hypertension or reflux and the expression of various subtypes of MMPs, or role of each subtype of MMPs, in creating morphologic changes is still controversial [2] . This study is focused on comparing the level of expression of MMP-2, MMP-13, and tissue inhibitor of metalloproteinase-4 (TIMP-4) between VV and non-varicose veins in order to investigate the relationship between the expression of MMPs and the clinical characteristics related to reflux in VV. The mean age of the patients with VV was 52.5 (range 19 ∼73) and 78.3% (n=18) were female. The patients' characteristics based on the classification of chronic venous disease in the "Reporting standards in venous disease" [3] are presented in Table 1 
RESULTS
The patients' clinical characteristics including their symptoms, the duration of symptoms, and grade of reflux on duplex ultrasonography are presented in Table 2 . Twenty (87%) patients had greater or lesser saphenous vein disease with reflux. Ligation of the sapheno-femoral or sapheno-popliteal junction with stripping was performed for 17 patients and endovenous laser coagulation with additional individual excisions was performed for 6 patients.
Immunohistochemical analysis showed that focal or diffuse strong staining for MMP-2 and MMP-13 tended to be prominent in the control group, whereas focal weak staining was prevalent in the disease group (Table 3) . No specimen showed diffuse strong staining for MMP-2 in the varicose vein group. Expression of TIMP-4 also showed a similar pattern to that of MMPs. Half (n=5) of the control group showed diffuse strong staining for TIMP-4, but strong stain- ing for TIMP-4 in the varicose vein group was not indentified. When focal or diffuse strong staining (＋＋ or ＋＋＋) is considered to identify a 'significantly stained group' and focal weak stain (＋) is considered to identify a 'group that is not significantly stained', the differences in the expression of MMP-2, MMP-13, and TIMP-4 between the disease and the control groups were all statistically significant (p＜0.001).
The relationship between the degree of reflux observed on the duplex ultrasonography or the duration of symptoms and expression of MMP-13 is presented in Table 4 , and there is no significant increase in expression of MMP-13 with a rise in the degree of reflux or a longer duration of symptoms (p=0.317 and p=0.654, respectively).
DISCUSSION
The etiologic factors causing structural changes observed in VV remain to be clarified. Although venous hypertension followed by valvular incompetence was believed to be the primary cause, the biochemical or molecular mechanisms connecting venous hypertension and structural changes are still unclear. Vascular wall remodeling is reported to be related to the activity of macrophages, smooth muscle cells, endothelial cells, fibroblasts [4] , MMPs, the enzymes secreted by macrophages, collagen, fibronectin, laminin, and other components of the extracellular matrix. 
